Literature DB >> 29785469

Early Detection of Cerebral Infarction After Focal Ischemia Using a New MRI Indicator.

Yukako Nakajo1,2, Qiang Zhao1,3, Jun-Ichiro Enmi4, Hidehiro Iida4, Jun C Takahashi3, Hiroharu Kataoka3, Keiko Yamato1, Hiroji Yanamoto5,6.   

Abstract

Prolongation of the T2 relaxation time, an increase in T2-weighted signal intensity (T2-SI), and a decrease in the apparent diffusion coefficient (ADC) calculated from diffusion-weighted images (DWI) on magnetic resonance imaging (MRI) are conventional indicators of the vasogenic (interstitial) or cytotoxic (cellular) cerebral edema that develops after ischemic stroke. However, these parameters obtained on stroke imaging have not given us a precise threshold at which we can determine the viability or vulnerability of the tissue, allowing us to decide on an intervention that will help reversible tissue in the acute phase. Here, we introduce a new indicator-the essential diffusion coefficient or EDC, calculated from the T2-SI and ADC-that permits detection of irreversible brain damage after induction of experimental, focal cerebral ischemia. Our three-vessel occlusion (3-VO) method (Yang et al. Eur Neurol 71:4-18, 2014) was applied to investigate early changes on 7-T MRI. In the 3-VO model, which targets only a part of the cortex, animals seldom die at least within 24 h. The T2-SI and the ADC value were monitored, starting at 60 min after reperfusion, and every 30-60 min, for 10 h after the induction of focal ischemia. The region of interest (ROI) was set in each of the following: (1) the ischemic core (the dead zone); (2) the medial border area (the dying/dead mixed zone, including the ischemic penumbra); (3) the lateral border area (the surviving zone after the ischemic stress, where the rCBF is above the threshold for death); and (4) The intact area (outside the ischemic zone). The diagnosis was made by histological analysis performed 24 h after reperfusion. Significant increases in the T2-SI were observed, in ROI-1 at 1 h, in ROI-2 at 2.5 h, and in ROI-3 at 4 h post-reperfusion (1.10, 1.11, or 1.11; > 1.10, respectively, p < 0.001). Significant reductions in the ADC were also observed in ROI-1, ROI-2, and ROI-3, at 1 h post-reperfusion (0.55, 0.52, or 0.58; < 0.60, respectively, p < 0.001), indicating that both types of cerebral edema develop simultaneously in the acute phase. In the EDC analysis, from 5.0 h post-reperfusion, the value in the dying/dead zone (ROI-1 and ROI-2) was consistently reduced to < 50%, showing repeated, significant differences from the value in the surviving zone (ROI-3). A reduction in the EDC to below 50% indicated irreversible tissue damage, with transformation to cerebral infarction. We could detect a sign of cerebral infarction (initial necrosis-like irreversible lesion) as early as 5.25 h after the onset of ischemia. Although the biological time that depends on the body weight must be different between mice and humans, the earliest irreversible tissue damage or tissue destruction (to have achieved the risk of hemorrhagic transformation) that progressed after invisible or silent cell death in the ultra-acute phase, seems to occur at a similar time point.

Entities:  

Keywords:  Brain imaging; Cellular edema; Diagnosis; EDC; Irreversible tissue damage

Mesh:

Year:  2018        PMID: 29785469     DOI: 10.1007/s12035-018-1073-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  69 in total

Review 1.  Application of magnetic resonance to animal models of cerebral ischemia.

Authors:  M Hoehn; K Nicolay; C Franke; B van der Sanden
Journal:  J Magn Reson Imaging       Date:  2001-11       Impact factor: 4.813

2.  Diffusion-weighted imaging studies of cerebral ischemia in gerbils. Potential relevance to energy failure.

Authors:  A L Busza; K L Allen; M D King; N van Bruggen; S R Williams; D G Gadian
Journal:  Stroke       Date:  1992-11       Impact factor: 7.914

3.  Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke.

Authors:  M G Lansberg; V N Thijs; M W O'Brien; J O Ali; A J de Crespigny; D C Tong; M E Moseley; G W Albers
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

4.  Prolonged mild hypothermia therapy protects the brain against permanent focal ischemia.

Authors:  H Yanamoto; I Nagata; Y Niitsu; Z Zhang; J H Xue; N Sakai; H Kikuchi
Journal:  Stroke       Date:  2001-01       Impact factor: 7.914

5.  Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia.

Authors:  J Astrup; L Symon; N M Branston; N A Lassen
Journal:  Stroke       Date:  1977 Jan-Feb       Impact factor: 7.914

6.  Comparison of diffusion-weighted MRI and CT in acute stroke.

Authors:  M G Lansberg; G W Albers; C Beaulieu; M P Marks
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

7.  Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke.

Authors:  M Shibata; S R Kumar; A Amar; J A Fernandez; F Hofman; J H Griffin; B V Zlokovic
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

Review 8.  Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique.

Authors:  Hiroji Yanamoto; Izumi Nagata; Yoichi Niitsu; Jing Hui Xue; Zhiwen Zhang; Haruhiko Kikuchi
Journal:  Exp Neurol       Date:  2003-08       Impact factor: 5.330

9.  Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy.

Authors:  H Benveniste; L W Hedlund; G A Johnson
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

10.  Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia.

Authors:  K Minematsu; L Li; M Fisher; C H Sotak; M A Davis; M S Fiandaca
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

View more
  8 in total

Review 1.  Application of advanced magnetic resonance imaging in glaucoma: a narrative review.

Authors:  Longdan Kang; Chao Wan
Journal:  Quant Imaging Med Surg       Date:  2022-03

Review 2.  The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review.

Authors:  Ke-Ru Li; An-Guo Wu; Yong Tang; Xiao-Peng He; Chong-Lin Yu; Jian-Ming Wu; Guang-Qiang Hu; Lu Yu
Journal:  Mol Neurobiol       Date:  2022-07-12       Impact factor: 5.682

3.  Classification Algorithm-Based fMRI Images for Evaluating the Effect of Yishen Tiaodu Acupuncture on the Recovery Period of Cerebral Infarction.

Authors:  Zhuo Feng; Miaomiao Hu; Wei Yuan; Xiaojun Zhao; Jiazhi Zeng; Kaibin Zhou
Journal:  Comput Intell Neurosci       Date:  2022-05-25

Review 4.  Animal models of stroke.

Authors:  Yanyu Li; Jingjing Zhang
Journal:  Animal Model Exp Med       Date:  2021-09-15

5.  Benefits of Endovascular Treatment in Late Window for Acute Ischemic Stroke Selected without CT Perfusion: A Real-World Study.

Authors:  Yuan Yang; Ting Cui; Zuoxiao Li; Jinglun Li; Ting Duan; Zhengzhou Yuan; Changyi Wang; Jincheng Wan; Cao Li; Shujiang Zhang; Ling Li; Fayun Hu; Bo Wu
Journal:  Clin Interv Aging       Date:  2022-04-22       Impact factor: 3.829

6.  Observation of the Effect of Nursing BPR on Thrombolytic Efficacy and Prognosis of Patients with Cerebral Infarction Based on CT Images.

Authors:  Shaomin Wang; Xiao Miao; Guanghui Zhang; Dandan Li; Li Xu
Journal:  Contrast Media Mol Imaging       Date:  2022-09-14       Impact factor: 3.009

7.  Twenty-four-hour real-time continuous monitoring of acute focal cerebral ischemia in rabbits based on magnetic inductive phase shift.

Authors:  Shuang-Lin Zhao; Gui Jin; Ze-Lin Bai; Jing-Bo Chen; Meng-Wei Li; Gen Li; Wei Zhuang; Yue-Ning Liu; Ming-Xin Qin
Journal:  Biomed Eng Online       Date:  2020-11-11       Impact factor: 2.819

8.  Circular RNA expression alteration and bioinformatics analysis in patients with acute cerebral infarction injury.

Authors:  Xiao-Lei Hu; Qian Su; de-Long Meng; Yuan-Shui Ren; Zhi-Qiang Su
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.